278 related articles for article (PubMed ID: 33721148)
81. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW
Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691
[TBL] [Abstract][Full Text] [Related]
82. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Donker M; van Tienhoven G; Straver ME; Meijnen P; van de Velde CJ; Mansel RE; Cataliotti L; Westenberg AH; Klinkenbijl JH; Orzalesi L; Bouma WH; van der Mijle HC; Nieuwenhuijzen GA; Veltkamp SC; Slaets L; Duez NJ; de Graaf PW; van Dalen T; Marinelli A; Rijna H; Snoj M; Bundred NJ; Merkus JW; Belkacemi Y; Petignat P; Schinagl DA; Coens C; Messina CG; Bogaerts J; Rutgers EJ
Lancet Oncol; 2014 Nov; 15(12):1303-10. PubMed ID: 25439688
[TBL] [Abstract][Full Text] [Related]
83. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
[TBL] [Abstract][Full Text] [Related]
84. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients.
Canavese G; Gipponi M; Catturich A; Vecchio C; Tomei D; Nicoló G; Carli F; Spina B; Bonelli L; Villa G; Buffoni F; Bianchi P; Agnese A; Mariani G
J Surg Oncol; 2001 Jun; 77(2):81-7; discussion 88. PubMed ID: 11398158
[TBL] [Abstract][Full Text] [Related]
85. Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node.
Meattini I; Saieva C; Bertocci S; Francolini G; Zei G; De Luca Cardillo C; Scotti V; Greto D; Bonomo P; Orzalesi L; Bianchi S; Livi L
Tumori; 2015; 101(1):78-83. PubMed ID: 25702658
[TBL] [Abstract][Full Text] [Related]
86. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.
Kuerer HM; Newman LA; Fornage BD; Dhingra K; Hunt KK; Buzdar AU; Ames FC; Ross MI; Feig BW; Hortobagyi GN; Singletary SE
Ann Surg Oncol; 1998 Dec; 5(8):673-80. PubMed ID: 9869512
[TBL] [Abstract][Full Text] [Related]
87. Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study.
Gobardhan PD; Elias SG; Madsen EV; van Wely B; van den Wildenberg F; Theunissen EB; Ernst MF; Kokke MC; van der Pol C; Borel Rinkes IH; Wijsman JH; Bongers V; van Gorp J; van Dalen T
Ann Surg Oncol; 2011 Jun; 18(6):1657-64. PubMed ID: 21153885
[TBL] [Abstract][Full Text] [Related]
88. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.
Mougalian SS; Hernandez M; Lei X; Lynch S; Kuerer HM; Symmans WF; Theriault RL; Fornage BD; Hsu L; Buchholz TA; Sahin AA; Hunt KK; Yang WT; Hortobagyi GN; Valero V
JAMA Oncol; 2016 Apr; 2(4):508-16. PubMed ID: 26720612
[TBL] [Abstract][Full Text] [Related]
89. Patients with positive axillary lymph nodes: how to use genomic assays.
Rao R
Curr Treat Options Oncol; 2012 Jun; 13(2):240-8. PubMed ID: 22426945
[TBL] [Abstract][Full Text] [Related]
90. De-escalating Locoregional Therapy for Axillary Micrometastases in Breast Cancer: How Much is Too Much?
Merfeld EC; Burr AR; Brickson C; Neuman HB; Anderson BM
Clin Breast Cancer; 2022 Jun; 22(4):336-342. PubMed ID: 35105500
[TBL] [Abstract][Full Text] [Related]
91. The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.
Lips DJ; Koebrugge B; Liefers GJ; van de Linden JC; Smit VT; Pruijt HF; Putter H; van de Velde CJ; Bosscha K
BMC Surg; 2011 May; 11():11. PubMed ID: 21569373
[TBL] [Abstract][Full Text] [Related]
92. Impact of Post-Mastectomy Radiation Therapy for Sentinel Lymph Node Micrometastases in Early-Stage Breast Cancer Patients.
Luo H; Yang OO; He JL; Lan T
Med Sci Monit; 2022 Jan; 28():e933275. PubMed ID: 35094003
[TBL] [Abstract][Full Text] [Related]
93. Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort
Houvenaeghel G; de Nonneville A; Cohen M; Chopin N; Coutant C; Reyal F; Mazouni C; Gimbergues P; Azuar AS; Chauvet MP; Classe JM; Daraï E; Martinez A; Rouzier R; de Lara CT; Lambaudie E; Barrou J; Goncalves A
ESMO Open; 2021 Jun; 6(3):100151. PubMed ID: 33984674
[TBL] [Abstract][Full Text] [Related]
94. Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy-results from the prospective multi-center BRENDA II study.
Leinert E; Schwentner L; Janni W; Wöckel A; Herbert SL; Herr D; Kühn T; Flock F; Felberbaum R; Kreienberg R; Fink V; Dayan D; Ernst K; Singer S;
Breast Cancer; 2022 May; 29(3):429-436. PubMed ID: 35178667
[TBL] [Abstract][Full Text] [Related]
95. Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection.
Li B; Liu J; Wu G; Zhu Q; Cang S
Front Surg; 2022; 9():905437. PubMed ID: 36684123
[TBL] [Abstract][Full Text] [Related]
96. Negative Survival Impact of Occult Lymph Node Involvement in Small HER2-Positive Early Breast Cancer Treated by Up-Front Surgery.
Houvenaeghel G; Cohen M; Martino M; Reyal F; Classe JM; Chauvet MP; Colombo PE; Heinemann M; Jouve E; Gimbergues P; Azuar AS; Coutant C; Gonçalves A; de Nonneville A
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760536
[TBL] [Abstract][Full Text] [Related]
97. Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB Analysis.
Weiser R; Polychronopoulou E; Haque W; Hatch SS; He J; Qiu S; Markowitz A; Gradishar WJ; Kuo YF; Klimberg VS
Ann Surg Oncol; 2021 Dec; 28(13):8717-8727. PubMed ID: 34250555
[TBL] [Abstract][Full Text] [Related]
98. Specific diagnosis of lymph node micrometastasis in breast cancer by targeting activatable near-infrared fluorescence imaging.
Zhao D; Xu M; Yang S; Ma H; Li H; Wu R; He Y; Wang S; Liang X
Biomaterials; 2022 Mar; 282():121388. PubMed ID: 35151934
[TBL] [Abstract][Full Text] [Related]
99. Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.
Diessner J; Wischnewsky M; Blettner M; Häusler S; Janni W; Kreienberg R; Stein R; Stüber T; Schwentner L; Bartmann C; Wöckel A
PLoS One; 2016; 11(12):e0168730. PubMed ID: 27992550
[TBL] [Abstract][Full Text] [Related]
100. Bone marrow micrometastases in early breast cancer-30-year outcome.
Mansi J; Morden J; Bliss JM; Neville M; Coombes RC
Br J Cancer; 2016 Feb; 114(3):243-7. PubMed ID: 26766739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
